Gene therapy market Report 2025: Trends, Growth, and Key Players Forecast to 2035 | Spark Therapeutics , Novartis , Bluebird Bio , Gilead Sciences , Biogen

The Gene Therapy market accounted for USD 10.8 Billion in 2024 and is expected to reach USD 118.2 Billion by 2035, growing at a CAGR of around 24.3% between 2025 and 2035. Gene therapy is a specialized area of personalized medicine that seeks to treat genetic problems by supplementing, replacing, or changing the patient's genes. It seems to fix or provide a substitute for abnormal genes that lead to disease, often offering permanent or semipermanent treatment. There is potential for its use in any number of afflictions, including various hereditary disorders and some types of cancers and viruses. The gene therapy market encompasses medicines in development, clinical trials, and currently existing treatments, technology, tools, and services needed for gene editing and delivery systems. Bioinformatics is an emerging field with significant applied capital and investment focus owing to advancements in molecular biology and genetic engineering.

Get a Sample Copy of This Report
@ https://www.metatechinsights.com/request-sample/1244

Industry Experts Opinion
"The ability to precisely edit the genome opens the door to treating diseases at their genetic roots, but it will require sustained investment and research to realize its full potential, focusing on the application of CRISPR in gene therapy"
• Jennifer Doudna, co-discoverer of CRISPR gene-editing technology.

Segment Analysis
1. Market Type:
2. The Gene Therapy Market is classified into Gene Editing, Gene Replacement Therapy, Gene Silencing Therapy, Gene Immunotherapy, Gene Augmentation Therapy, and others.
• Gene Editing is the most significant segment, driven by advances in CRISPR technology. It offers the potential to correct genetic mutations at the DNA level, making it a promising treatment for inherited genetic diseases, cancers, and other conditions.
1. Vector Type:
2. Gene therapy is also divided by vector type into Viral Vectors and Non-Viral Vectors.
• Viral Vectors dominate the market due to their efficient gene delivery capabilities. Adeno-associated viruses (AAV), lentiviruses, and adenoviruses are commonly used, despite some safety concerns, because of their success in clinical trials for genetic disorders and cancer therapies.
1. Regional Analysis:
• North America leads the gene therapy market, driven by advanced biotechnology, strong R&D investments, and regulatory support. The U.S. is a key player, with high incidences of genetic diseases and cancer, creating strong demand for gene therapies. Regulatory bodies like the FDA are accelerating approval processes, further encouraging market growth.
• Asia-Pacific is growing rapidly, particularly in China, Japan, and India, thanks to increasing healthcare spending and the adoption of CRISPR technology. However, challenges like high treatment costs and policy barriers exist. Strategic partnerships and increasing public awareness are helping accelerate growth in the region.
1. Competitive Landscape:
2. Leading players in the market include Novartis, Spark Therapeutics (Roche), Bluebird Bio, Gilead Sciences, and CRISPR Therapeutics.
• Novartis launched Zolgensma, a gene therapy for spinal muscular atrophy.
• CRISPR Therapeutics and Intellia Therapeutics are pioneering CRISPR/Cas9 technology, with promising treatments like CTX001 for sickle cell disease.
• Other notable therapies include UniQure's Hemgenix and Spark's Luxturna for inherited retinal disorders. These companies are at the forefront of transforming treatments for genetic diseases.

Report Coverage:
By Type
• Gene Editing
• Gene Replacement Therapy
• Gene Silencing Therapy
• Gene Immunotherapy
• Gene Augmentation Therapy
• Others

By Vector Type
• Viral Vectors
• Adeno-Associated Virus (AAV) Vectors
• Lentiviral Vectors
• Adenoviral Vectors
• Herpes Simplex Virus (HSV) Vectors
• Others
• Non-Viral Vectors
• Lipid Nanoparticles
• Polymers
• Others

By Therapeutic Area
• Cardiovascular Disorders
• Dermatological Disorders
• Genetic Disorders
• Hematological Disorders
• Metabolic Disorders
• Oncological Disorders
• Ophthalmic Disorders
• Other Disorders

By Delivery Method
• In-Vivo
• Ex-Vivo

By Route of Administration
• Intravenous
• Topical
• Inhalation
• Others

By End-User
• Hospitals
• Research Institutions
• Pharmaceutical and Biotechnology Companies

By Region
North America
• U.S.
• Canada
Europe
• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific
Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC Countries
• South Africa
• Rest of the Middle East & Africa

Get a Customization Report
@ https://www.metatechinsights.com/customize-report/1244

Leading key players
• Spark Therapeutics
• Novartis
• Bluebird Bio
• Gilead Sciences
• Biogen
• Editas Medicine
• Intellia Therapeutics
• CRISPR Therapeutics
• Amgen
• Regeneron Pharmaceuticals
• UniQure
• Sarepta Therapeutics
• Voyager Therapeutics
• Orchard Therapeutics
• Pfizer


Inquiry Before Buying
@ https://www.metatechinsights.com/inquiry-before-buying/1244

Frequently Asked Questions (FAQs)
What is the Gene Therapy Market size in 2024 and how it will evolve through 2035?
What are the key growth opportunities in the Gene Therapy Market?
Which are the largest and fastest-growing segments in the Gene Therapy Market?
Which region will make a notable contribution to the Global Gene Therapy Market?
Who are the leading players operating in the global Gene Therapy Market?

Address :
50 MacAleese Lane #24, Moncton, New Brunswick, E1A 3L9, Canada

Contact Us:
Web: www.metatechinsights.com
Ph: US - +1 5064 048 481
Email: sales@metatechinsights.com

About Us:
Metatech Insights specializes in making comprehensive global and regional market research reports in Healthcare, Medical Devices, Healthcare IT, Agriculture, Chemicals and Materials, Consumer Goods, Food & Beverages, Pet Care, Cryptocurrency, and Novel technologies. Our meticulously designed research reports are regarded as one of the most detailed and well-thought market research studies available in the industry. Our reports typically include market assessments, analysis of industry trends, and competitive intelligence.

This release was published on openPR.